Evidence map›Paper›PMID 36551716›Full record

ReviewCancers2022

Diagnostic and Prognostic Deep Learning Applications for Histological Assessment of Cutaneous Melanoma.

Sydney R Grant, Tom W Andrew, Eileen V Alvarez, Wendy J Huss, Gyorgy Paragh

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Overdiagnosis in Melanoma Screening: Is It a Real Problem?Dermatology practical & conceptual · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sydney R GrantDepartment of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Tom W AndrewTranslational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne NE2 4HH, UK.
Eileen V AlvarezDepartment of Pathology and Anatomical Sciences, University at Buffalo, Buffalo, NY 14260, USA.
Wendy J HussDepartment of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Gyorgy ParaghDepartment of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-6612-9267

Funding

Roswell Park Alliance Foundation Roswell Park Alliance Foundation
6 · The paper itself

Abstract

Melanoma is among the most devastating human malignancies. Accurate diagnosis and prognosis are essential to offer optimal treatment. Histopathology is the gold standard for establishing melanoma diagnosis and prognostic features. However, discrepancies often exist between pathologists, and analysis is costly and time-consuming. Deep-learning algorithms are deployed to improve melanoma diagnosis and prognostication from histological images of melanoma. In recent years, the development of these machine-learning tools has accelerated, and machine learning is poised to become a clinical tool to aid melanoma histology. Nevertheless, a review of the advances in machine learning in melanoma histology was lacking. We performed a comprehensive literature search to provide a complete overview of the recent advances in machine learning in the assessment of melanoma based on hematoxylin eosin digital pathology images. In our work, we review 37 recent publications, compare the methods and performance of the reviewed studies, and highlight the variety of promising machine-learning applications in melanoma histology.

Indexed as

deep learningdermatopathologymelanoma

Identifiers

PMID36551716
PMCPMC9776963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.